Evaluation of clinical results and level of interleukin 6 using 20% albumin in comparison with prime voluven colloid sample in CABG surgery

Phase 2

Recruiting

• Conditions: Coronary artery heart disease.; Atherosclerotic heart disease of native coronary artery; I25.1

• Registration Number: IRCT20220410054470N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patient age between 40 to 75
Ejection fraction>35%
Non-emergency surgery
Discontinue aspirin and Plavix 48 hours before surgery

Exclusion Criteria

Children
Candidate patients for cardiac surgery without using cardiopulmonary bypass device
End Stage patients
patients with liver failure
patients with kidney failure
Patients with preoperative infections such as infectious endocarditis
Patients with recent inflammation
Patients with recent MI

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin6. Timepoint: Measurement of interleukin 6 twelve hours after coronary heart surgery. Method of measurement: test.

Secondary Outcome Measures

Name	Time	Method
Postoperative drainage rate of coronary artery bypass graft surgery. Timepoint: 48 hours after coronary aetery bypass graft surgery. Method of measurement: Chest bottle.;Rate of blood products received after coronary artery bypass graft surgery. Timepoint: 48 hours after coronary artery bypass graft surgery. Method of measurement: Check the blood sheet in the patient's file.